SCHEMBL6162759

SCHEMBL6162759

CCOC(=O)c1cc2c([N+](=O)[O-])c(Cl)ccc2[nH]1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.50
KDM4E B2RXH2 6/20 0.49
ALDH1A1 P00352 6/20 0.49
RAB9A P51151 4/20 0.49
HPGD P15428 4/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
HSD17B10 Q99714 1/20 0.49
NPC1 O15118 2/20 0.46
LMNA P02545 2/20 0.46
HTT P42858 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
HRH3 Q9Y5N1 1/20 0.46
MMP13 P45452 4/20 0.45
MMP2 P08253 3/20 0.45
MAPT P10636 3/20 0.45
MEN1 O00255 2/20 0.45
GAA P10253 2/20 0.45
KMT2A Q03164 2/20 0.45
GLA P06280 1/20 0.45
ATM Q13315 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4376277 0.86 KDM4E (0.50) ALOX15KDM4EALDH1A1RAB9AHPGD
SCHEMBL699665 0.82 ALOX15 (0.57) ALOX15KDM4EALDH1A1RAB9AHPGD
SCHEMBL7954222 0.82 ALOX15 (0.57) ALOX15KDM4EALDH1A1RAB9AHPGD
SCHEMBL30525427 0.82 ALOX15 (0.57) ALOX15KDM4EALDH1A1RAB9AHPGD
SCHEMBL6161781 0.80 GRIN1 (0.49) KDM4EALDH1A1HPGDHSD17B10LMNA
SCHEMBL4403101 0.80 ALOX15 (0.54) ALOX15KDM4EALDH1A1RAB9AHPGD
SCHEMBL27621667 0.80 ALOX5 (0.44) KDM4EALDH1A1RAB9AHPGDHSD17B10
SCHEMBL7665437 0.78 CDK1 (0.54) ALOX15KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL13087128 0.78 ALDH1A1 (0.61) ALOX15KDM4EALDH1A1RAB9AHPGD
SCHEMBL7665395 0.78 FBP1 (0.53) ALOX15ALDH1A1LMNAMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1134213-B1 Process for the preparation of substituted N-(indole-2-carbonyl)- glycinamides PFIZER (US) 2005-11-02 EP disclosed
EP-0832065-B1 SUBSTITUTED N-(INDOLE-2-CARBONYL)-GLYCINAMIDES AND DERIVATIVES AS GLYCOGEN PHOSPHORYLASE INHIBITORS PFIZER (US) 2001-10-10 EP disclosed
EP-1134213-A2 Process for the preparation of substituted N-(indole-2-carbonyl)- glycinamides PFIZER INC. (US) 2001-09-19 EP disclosed
US-6277877-B1 GLYCOGEN PHOSPHORYLASE INHIBITOR; ANTIDIABETIC AGENTS PFIZER, INC. 2001-08-21 US disclosed
US-6107329-A HYPOTENSIVE AGENTS; CARDIOVASCULAR DISORDERS PFIZER, INC. (US) 2000-08-22 US disclosed
EP-0832065-A1 SUBSTITUTED N-(INDOLE-2-CARBONYL)-GLYCINAMIDES AND DERIVATIVES AS GLYCOGEN PHOSPHORYLASE INHIBITORS PFIZER INC. (US) 1998-04-01 EP disclosed
WO-1996039384-A1 SUBSTITUTED N-(INDOLE-2-CARBONYL)-GLYCINAMIDES AND DERIVATIVES AS GLYCOGEN PHOSPHORYLASE INHIBITORS PFIZER, INC. (US) 1996-12-12 WO disclosed